Creative Biolabs provides transcriptomic assessment, quantifying differential gene expression and RNA-seq profiles. We utilize NGS and bioinformatics to evaluate signaling pathway modulation and biomarker signatures for oncology drug discovery.
Learn More →Cancer Signaling Pathway Mapping Services
In the landscape of precision medicine, identifying a mutation is no longer enough. Creative Biolabs bridges the gap between genomic data and functional biology. Our services provide a "live map" of how signals flow through a cell, identifying not just the primary drivers of growth, but the hidden bypass loops and non-canonical "moonlighting" functions that lead to therapeutic failure. By quantifying the activation state of the 10 canonical signaling pathways, we ensure your lead candidates are evaluated against the full spectrum of cellular plasticity.
Background Featured Services Workflow Publication Why Choose Us FAQs Customer Review Related Services Contact Us
Navigating the Complexity of the Cancer Signaling Landscape
The paradigm of cancer research has fundamentally shifted from a gene-centric view to a network-centric understanding of malignancy. It is now widely recognized that genomic status frequently fails to predict actual pathway activation, creating significant hurdles for target validation and lead optimization. Modern therapeutic development requires a high-resolution map of the functional signaling circuitry to navigate the inherent plasticity of cancer cells. Tumors often utilize bypass loops, epigenetic rewiring, and non-canonical "moonlighting" functions of proteins to maintain growth and escape targeted inhibition. Our cancer signaling pathway mapping services address this need by quantifying the real-time activation state of the cellular network.
Comprehensive Analytical Suites for Functional Pathway Decipherment
Creative Biolabs offers an expansive suite of technical offerings designed to resolve the most complex signaling enigmas.
Transcriptomic Assessment
Proteomic & Phosphoproteomic Profiling
Creative Biolabs provides proteomic and phosphoproteomic profiling, quantifying post-translational modifications and protein-related signaling. We utilize LC-MS/MS to evaluate phosphorylation-driven crosstalk and novel oncology therapeutic targets.
Learn More →Kinase Activity Profiling
Creative Biolabs provides kinase activity profiling, quantifying phospho-protein signaling and enzymatic kinetics. We utilize bioluminescent assays and radioactive labeling to evaluate cross-talk nodes and therapeutic resistance in cancer pathways.
Learn More →Network Reconstruction & Causal Inference
Creative Biolabs provides network reconstruction and causal inference, quantifying regulatory nodes and pathway crosstalk. We utilize unsupervised machine learning to evaluate SASP-driven signaling logic and identify high-fidelity therapeutic leads.
Learn More →Immune & TME Integration
Creative Biolabs provides immune and TME integration, quantifying SASP-driven signaling and spatial immune phenotyping. We utilize multiplex imaging to evaluate senescence-mediated immune escape and TME remodeling.
Learn More →Explore Our Technical Capabilities - Inquire about our specialized platforms to identify the 'moonlighting' functions driving your project's resistance.
Workflow
To provide a comprehensive view of the tumor's operational logic, we follow a rigorous, stage-gated workflow designed for maximum data fidelity and scientific rigor.
Publication
This review discusses targeted cancer therapies directed at key signaling pathways, including hormone receptors, RTKs, PI3K/AKT, Ras/MAPK, CDKs, and DNA damage repair. It highlights mechanisms of therapy resistance and the potential of combination treatments to overcome them. The authors also explore emerging approaches such as proteolysis-targeting chimeras and functional genomics to identify novel therapeutic vulnerabilities.
Fig.1 Targeting cell cycle and DNA damage repair pathways in cancer. 1
Why Choose Us?
Creative Biolabs stands at the forefront of oncology research, offering a synthesis of two decades of expertise and sophisticated analytical platforms. Our unique advantage lies in our ability to look beyond canonical pathways to uncover the operational logic of malignancy. While standard services might provide raw RNA-seq or genomic data, we provide deep biological context by mapping the actual flow of signals through the cellular network. We specialize in detecting functional signatures in tumors that lack traditional mutations, particularly within the Ras and PI3K axes, where genomic status often fails to predict therapeutic response. Our mastery of developmental pathways allows us to pinpoint the mechanisms governing cancer stem cell survival and epithelial-mesenchymal transition.
Experience the Creative Biolabs Advantage - Secure a technical quote today and partner with PhD-level experts to de-risk your therapeutic assets.
FAQs
My project already has genomic (WGS) data. Why do I need functional mapping?
Genomic data identifies the "potential" for activation, but not the "actual" signaling flow. Many tumors utilize feedback loops to activate pathways even without mutations.
Can you map signaling in the context of the tumor microenvironment (TME)?
Absolutely. We use spatial transcriptomics and mechanical signaling assays to see how factors like ECM stiffness and hypoxia activate hubs.
How do you handle non-canonical or 'moonlighting' protein functions?
We use fractionation-linked proteomics to track protein translocation between organelles, ensuring we catch signaling molecules acting outside their traditional roles.
Customer Review
-
Accelerated Our MoA Documentation
The functional pathway scoring provided by the team was instrumental in our MoA dossier. They identified a JAK/STAT bypass loop that we had completely missed using RNA-seq alone. It saved us months of trial and error. - Sarah M***z -
Precise Mapping of CSC Markers
Integrating the Stemness Signature mapping into our lead optimization phase allowed us to prioritize molecules that specifically targeted Notch-active populations. Highly recommend for any project focused on preventing relapse. - Prof. R***rt H
Related Services
To achieve a complete biological profile, we recommend exploring these complementary offerings:
Smooth Muscle Cell Immunophenotyping Service
Creative Biolabs provides SMC immunophenotyping, quantifying contractile and synthetic phenotypes. We utilize custom antibody panels and scRNA-seq to evaluate phenotypic plasticity and spatial dynamics for vascular and regenerative medicine research.
Learn More →Photoacoustic Tumor Imaging Service
Creative Biolabs provides photoacoustic imaging, quantifying endogenous hemoglobin and exogenous nanomaterial contrast. We utilize pulsed-light technology to evaluate high-resolution tumor cell fate and real-time molecular dynamics non-invasively.
Learn More →How to Contact Creative Biolabs
Creative Biolabs provides comprehensive cancer signaling pathway mapping services, moving beyond genomics to provide functional, actionable biological insights. Whether you are battling adaptive resistance or seeking to validate a first-in-class target, our multi-omic platforms deliver the resolution you need to succeed.
Our team of expert scientists is ready to discuss the specific requirements of your oncology project. Contact Our Team for More Information and to Discuss Your Project
Reference
- Yip, H. Y. K., and A. Papa. "Signaling Pathways in Cancer: Therapeutic Targets, Combinatorial Treatments, and New Developments." Cells 10.3 (2021). Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/cells10030659
Download our brochureLoading case studies...
Online Inquiry